Xilio Therapeutics grants inducement stock options for 205,895 shares at $8.91 each

Bitget2026/10/02 20:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Xilio Therapeutics granted inducement stock options covering 205,895 shares, effective Oct. 1, 2026.
Includes options for new Chief Medical Officer Yariv Houvras totaling 105,000 shares.
Exercise price set at USD 8.91 per share, matching the Oct. 1 closing price.
Options run 10 years; 25% vests after one year, balance vests monthly over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021630PRIMZONEFULLFEED9838407) on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Xilio Therapeutics grants inducement stock options for 205,895 shares at $8.91 each

You may also like

Crypto prices